(Shhhh...only Africans were infected. No need to heal them) Its development stalled in part because Ebola is rare, and until now, outbreaks had infected only a few hundred people at a time. But experts also acknowledge that the absence of follow-up on such a promising candidate reflects a broader failure to produce medicines and vaccines for diseases that afflict poor countries. Most drug companies have resisted spending the enormous sums needed to develop products useful mostly to countries with little ability to pay.
Posted on: Sat, 25 Oct 2014 16:20:51 +0000
Trending Topics
Recently Viewed Topics
© 2015